AVIGI Therapeutics

AVIGI Therapeutics is at the forefront of biotechnology research, pioneering a new era in drug design and development. Leveraging human capabilities in advanced chemistry and biotech advancements, AVIGI Therapeutics employs a rational design approach, offering a paradigm shift in disease treatment and making the untreatable, treatable. Their innovative approach centers around biomimicry, selectively targeting central cascades that drive disease.

With a focus on rational design in therapeutics, AVIGI Therapeutics is dedicated to modifying disease outcomes for millions of patients. Their lead program is currently in development for kidney disease, showcasing their commitment to addressing significant medical needs. AVIGI Therapeutics is dedicated to improving healthcare through cutting-edge research and development.

AVIGI Therapeutics continues to push the boundaries of what's possible in the realm of biotechnology. More detailed information about AVIGI Therapeutics will be completed soon with the support of the company’s management.

We invite the manager of AVIGI Therapeutics to create a customized and exclusive company showcase and product listing on our platform.